Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer a Phase II Trial

NCT00844506 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT00844506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00844506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer a Phase II Trial
Lead sponsor
University Medical Center Groningen
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2008
Completion date
July 31, 2009
Enrollment
19 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer